Paclitaxel News and Research

RSS
Paclitaxel is a drug used to treat breast cancer, ovarian cancer, and AIDS-related Kaposi sarcoma. It is also used together with another drug to treat non-small cell lung cancer. Paclitaxel is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimitotic agent. Also called Taxol.

The Paclitaxel compound is extracted from the Pacific yew tree Taxus brevifolia with antineoplastic activity. Paclitaxel binds to tubulin and inhibits the disassembly of microtubules, thereby resulting in the inhibition of cell division. This agent also induces apoptosis by binding to and blocking the function of the apoptosis inhibitor protein Bcl-2 (B-cell Leukemia 2). Check for active clinical trials or closed clinical trials using this agent.
Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

New genetic classifier can predict the sensitivity of chemotherapy for breast cancer

New genetic classifier can predict the sensitivity of chemotherapy for breast cancer

Constitutive BAK/MCL1 complexes could predict sensitivity of chemotherapy drugs, research shows

Constitutive BAK/MCL1 complexes could predict sensitivity of chemotherapy drugs, research shows

Novel nano drug candidate kills triple negative breast cancer cells

Novel nano drug candidate kills triple negative breast cancer cells

Study shows how inflammatory changes in tumors cause drug resistance in blood vessels

Study shows how inflammatory changes in tumors cause drug resistance in blood vessels

Scientists find gene signature linked to worst prognosis in rare uterine cancer

Scientists find gene signature linked to worst prognosis in rare uterine cancer